Nashville, TN, United States of America

Matthew Spock

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Matthew Spock

Introduction

Matthew Spock is an accomplished inventor based in Nashville, TN. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific receptors in the brain. His work has the potential to impact the treatment of various disorders.

Latest Patents

Matthew Spock holds a patent for "Antagonists of the muscarinic acetylcholine receptor M4." This patent discloses substituted hexahydro-1H-cyclopenta[c]pyrrole compounds, which may serve as antagonists of the muscarinic acetylcholine receptor M4. The patent also outlines methods for synthesizing these compounds, pharmaceutical compositions that include them, and methods for treating disorders using these compounds and compositions.

Career Highlights

Matthew Spock is affiliated with Vanderbilt University, where he conducts research and develops innovative solutions in pharmacology. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Craig William Lindsley and P. Jeffrey Conn, contributing to a rich environment of innovation and discovery.

Conclusion

Matthew Spock's contributions to the field of pharmacology through his patent and research at Vanderbilt University highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…